Report: Ohio's medical marijuana program hindered by lack of improvements, high costs
By Jeremy Nobile for Crain's Cleveland Business
State-level medical cannabis programs are suffering from a lack of improvements and high consumer costs, especially in markets like Ohio, according to the 2022 State of States report from Americans for Safe Access (ASA), a Washington, D.C., nonprofit that advocates for the therapeutic use and research of medical marijuana.
The ASA grades every state (plus U.S. territories and Washington, D.C.) on their medical programs based on a variety of criteria in seven categories, including program functionality, affordability and patient rights/civil protections.
Share this page